Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    • Implants / Devices
    • MTaI to work closely...

    MTaI to work closely with DoP, Invest India to promote investments in medical device sector

    Medical Dialogues BureauWritten by Medical Dialogues Bureau Published On 2019-11-30T12:42:24+05:30  |  Updated On 16 Aug 2021 2:40 PM IST

    "MTaI has been engaging with the Department of Pharmaceuticals and the Invest India team closely to work on several corrective measures which will help bring FDI back on track and promote investments in the medical device sector," Choudary said.


    New Delhi: Government's directive to states to prefer domestically manufactured medical devices for public procurement could lead to restricting of competition, industry body Medical Technology Association of India (MTaI) has said. The timing of the directive, issued this month, is surprising as the industry is actively discussing the means to streamline public procurement of medical devices without disturbing the demand-supply equation, MTaI said in a statement.


    "The central government's directive to states to prefer indigenously manufactured medical devices for public procurement may end up restricting competition rather than creating a level-playing field," it added.


    It is noteworthy that more than 70 per cent of the demand for medical devices is being met by global companies with a large footprint of investment in manufacturing, research and development and training of healthcare workers in India, the statement said.


    These companies operate in multiple countries and therefore adhere to international standards such as USFDA or CE that are recognised in India as well as all other nations, it added.


    The recent directive seems to have ignored these facts in asking states to prefer Indian drug regulatory certification for public procurement, the statement said.


    Earlier in 2018, the Central Government had issued draft guidelines for public procurement, stipulating that medical devices should have a minimum local content of 25-50 per cent to qualify for public procurement, it added.


    At present, India has got adequate manufacturing capabilities for products like syringes, cannulae, stop cocks, dressings, hospital furniture, etc but lacks the desired ecosystem for devices like heart-lung machines, pacemakers, complex catheters among others, the statement said.


    "The definition of local content in public procurement tenders need to be reworked. Keeping the wide spectrum of products in the medical device sector in mind as well as staying mindful of the fact that no large company makes its entire range in one destination, a company that's making any part of this wide range of products in significant volume should be considered as domestic manufacturer," MTaI Chairman and DG Pavan Choudary said.


    While Department of Pharmaceuticals is taking an inclusive approach to understand the concerns of all stakeholders in the industry, measures such as the recent directive on public procurement seem to ignore the concerns of global companies, which are the largest stakeholder at present, he added.


    FDI in medical devices had dipped to USD 66 million in 2018 from USD 439 million in 2016, the statement said.


    "MTaI has been engaging with the Department of Pharmaceuticals and the Invest India team closely to work on several corrective measures which will help bring FDI back on track and promote investments in the medical device sector," Choudary said.


    This is a capital intensive and technology-intensive sector which is why for the growth of this sector, the participation of western countries and countries like Japan and Korea is vital, he added.


    Read Also: Scaling down customs duty of medical devices in Union budget to increase healthcare affordability, says MTal

    cannulaecatheterscentral govtDept of pharmadg pavan choudhardomestic medical devicesdressingsHealthcareheart lung machinesmedical deviceMedical DevicesMedical Technology Association of IndiaMTaIpacemakersstop cockssyringesUSFDA
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok